PAMELA BOYD: Open Payments
NPI 1033467527 · GRAYSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 21 payments from 5 companies in 2025. Trend: 2023 $285 · 2024 $280 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $158 |
| GENZYME CORPORATION | 4 | $103 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: DUPIXENT, RINVOQ, VIBERZI, SKYRIZI, CREON, OCALIVA, ENTYVIO.
Industry payments across GA — which companies pay providers there.
